Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59.6M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
38.5M
-
Shares change
-
+2.4M
-
Total reported value, excl. options
-
$171M
-
Value change
-
+$11.5M
-
Put/Call ratio
-
1
-
Number of buys
-
43
-
Number of sells
-
-54
-
Price
-
$4.45
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q1 2022
140 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2022.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.5M shares
of 59.6M outstanding shares and own 64.68% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (9.9M shares), BlackRock Inc. (3.22M shares), VANGUARD GROUP INC (2.96M shares), CITADEL ADVISORS LLC (2.48M shares), Verition Fund Management LLC (2.11M shares), EAGLE ASSET MANAGEMENT INC (1.47M shares), Tri Locum Partners LP (1.45M shares), Prosight Management, LP (1.4M shares), GOLDMAN SACHS GROUP INC (1.39M shares), and Assenagon Asset Management S.A. (975K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.